selected publications
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Oncoimmunology.
2023
Review
GET IT
Times cited: 2 - Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2023 Academic Article GET IT
- Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2022 Editorial Article GET IT
-
Parallels Between the Antiviral State and the Irradiated State.
Journal of the National Cancer Institute.
2021
Academic Article
GET IT
Times cited: 6 - The role of dendritic cells in cancer and anti-tumor immunity. Seminars in immunology. 2021 Information Resource GET IT
-
Radiation Therapy and the In Situ Vaccination Approach.
International journal of radiation oncology, biology, physics.
2020
Information Resource
GET IT
Times cited: 10 -
Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer.
Advances in radiation oncology.
2020
Academic Article
GET IT
Times cited: 8 -
CDK12 Gene Alterations in Prostate Cancer: Present, but Clinically Actionable?.
European urology.
2020
Editorial Article
GET IT
Times cited: 1 -
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.
World neurosurgery.
2019
Academic Article
GET IT
Times cited: 4 -
Role of noninvasive molecular imaging in determining response.
Advances in radiation oncology.
2018
Review
GET IT
Times cited: 22 -
Avelumab: is it time to get excited?.
Expert review of anticancer therapy.
2018
Editorial Article
GET IT
Times cited: 5 -
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2018
Academic Article
GET IT
Times cited: 229 -
The Winds of Change: Emerging Therapeutics in Prostate Cancer.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2018
Review
GET IT
Times cited: 1 -
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy.
Urologic oncology.
2018
Academic Article
GET IT
Times cited: 8 -
Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Current treatment options in oncology.
2018
Review
GET IT
Times cited: 6 -
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.
Cancer immunology research.
2018
Academic Article
GET IT
Times cited: 64 -
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.
Journal for immunotherapy of cancer.
2018
Conference Paper
GET IT
Times cited: 19 -
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
International journal of radiation oncology, biology, physics.
2017
Academic Article
GET IT
Times cited: 205 -
Avelumab demonstrates promise in advanced NSCLC.
Oncotarget.
2017
Editorial Article
GET IT
Times cited: 5 -
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.
Cancer immunology research.
2017
Academic Article
GET IT
Times cited: 168 -
Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy.
Frontiers in oncology.
2017
Academic Article
GET IT
Times cited: 20 -
Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study.
Neurosurgery.
2017
Academic Article
GET IT
Times cited: 9 -
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer.
Frontiers in oncology.
2017
Academic Article
GET IT
Times cited: 7 -
LAG3 (CD223) as a cancer immunotherapy target.
Immunological reviews.
2017
Review
GET IT
Times cited: 681 -
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.
Neuro-oncology.
2015
Academic Article
GET IT
Times cited: 98 -
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
Journal of neurosurgery.
2015
Academic Article
GET IT
Times cited: 60 -
3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.
European radiology.
2015
Academic Article
GET IT
Times cited: 14 -
Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature.
Case reports in oncological medicine.
2015
Academic Article
GET IT
Times cited: 11 -
Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β).
Growth factors (Chur, Switzerland).
2015
Academic Article
GET IT
Times cited: 8 -
Stereotactic body radiation therapy in pancreatic cancer: the new frontier.
Expert review of anticancer therapy.
2014
Review
GET IT
Times cited: 25 - Torus palatinus. 2014 GET IT
-
Is there a role for an external beam boost in cervical cancer radiotherapy?.
Frontiers in oncology.
2013
Academic Article
GET IT
Times cited: 14 -
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Cancer research.
2012
Academic Article
GET IT
Times cited: 203 -
Introduction to the medical professions through an innovative medical student-run pipeline program.
Journal of the National Medical Association.
2011
Academic Article
GET IT
Times cited: 15